OncoResponse, Inc of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2018-09-06. The offering totals $40.0M, of which $19.0M was reported sold. Industry: Biotechnology.
Showing 25 of 36 people.
| Name | Role | Location |
|---|---|---|
| Nathan Jorgensen | Director | Cambridge, MA |
| Andrew Perlman | Director | Atlanta, GA |
| Steve Gillis | Director | New York, NY |
| Steven Gillis | Director | South San Francisco, CA |
| Geeta Vemuri | Director | Waltham, MA |
| Sean A McCarthy | Director | HOUSTON, TX |
| Roberto D De Ponti | Director | HOUSTON, TX |
| Alice J Bexon | Executive Officer | HOUSTON, TX |
| Steven D Gillis | Director | HOUSTON, TX |
| Clifford J Stocks | Director | HOUSTON, TX |
| Clifford J Stocks | Executive Officer | HOUSTON, TX |
| Kamal D Puri | Executive Officer | HOUSTON, TX |
| Carol D Gallagher | Director | HOUSTON, TX |
| John A McKearn | Director | HOUSTON, TX |
| Chris D Russell | Executive Officer | HOUSTON, TX |
| Wende D Hutton | Director | HOUSTON, TX |
| TED KOUTOUZIS | Director | SANTA CLARA, CA |
| Wende Hutton | Director | Menlo Park, CA |
| Clifford Stocks | Director | Houston, TX |
| Clifford Stocks | Executive Officer | Houston, TX |
| Roberto De Ponti | Director | Philadelphia, PA |
| Roberto A DePonti | Director | None, N4 |
| Ted A Koutouzis | Director | Evanston, IL |
| Steven A Gillis | Director | Chicago, IL |
| Robert J Lechleider | Executive Officer | Seattle, WA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2025-05-06 | D | — | $6.0M |
| 2023-05-12 | D | $40.0M | $13.9M |
| 2021-03-31 | D | $60.0M | $40.6M |
| 2017-03-23 | D/A | $34.0M | $29.5M |
| 2016-05-26 | D/A | $28.2M | $19.5M |
| 2015-10-15 | D | $28.2M | $16.5M |